Insiders · LIAN

Anastasios Gianakakos

Director at LianBio (LIAN)

Anastasios Gianakakos has filed 3 insider reports with the SEC since June 2022, as director at LianBio (LIAN). The latest filing, on February 20, 2024, reports shares withheld for taxes or exercise price and exercise or conversion of a derivative at LianBio (LIAN).

Filings
3
Companies
1
Bought on market
None
Sold on market
None

Companies where Anastasios Gianakakos is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
LianBio logo
LIAN
LianBio
Director53,630Feb 20, 2024

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Anastasios Gianakakos with

Questions about Anastasios Gianakakos

What is Anastasios Gianakakos's role at LianBio?
Anastasios Gianakakos reports to the SEC as director at LianBio (LIAN), according to the latest filing on February 20, 2024.
How many shares does Anastasios Gianakakos own?
After the latest filing that states it, Anastasios Gianakakos directly owned 53,630 shares of LianBio (LIAN). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Anastasios Gianakakos bought or sold stock recently?
No open-market purchases or sales by Anastasios Gianakakos are on file. The filings report shares withheld for taxes or exercise price, exercise or conversion of a derivative and grant or award.
How do I get alerts when Anastasios Gianakakos files?
Follow Anastasios Gianakakos on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Anastasios Gianakakos (SEC CIK 0001413822). Totals count each trade once, skipping amendments whose original is on file, from Jun 27, 2022 on. View on SEC EDGAR · Get this as JSON